Tag: Biological Samples

Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease

Posted on by pathwp

The Global Biobank Meta-analysis Initiative (GBMI) unites 24 biobanks, including CanPath and its regional cohorts, with data from over 2.2 million people, to power global genetic discovery. By integrating diverse genetic info, GBMI improves disease risk prediction, advances personalized medicine, and boosts discoveries. CanPath contributes Canadian data, adding diversity and impact! Together, they’ve harmonized data, improved data on 14 diseases, and accelerated drug target discovery. The future? More inclusivity, better data sharing, and deeper disease insights.

CIHR Team Grants: Bringing Biology to Cancer Prevention

Posted on by pathwp

Team Grants — Bringing Biology to Cancer Prevention  This opportunity is led by the CIHR Institute of Cancer Research (CIHR-ICR) in collaboration with the CIHR Institutes of: Aging (CIHR-IA), Gender and Health (CIHR-IGH), Nutrition, Metabolism and Diabetes (CIHR-INMD), Population and Public Health (CIHR-IPPH), and in partnership with the BioCanRx, Canadian Cancer Society (CCS), Cancer Research Society (CRS), Japan Agency for Medical Research and Development (AMED) – Adopting Sustainable Partnerships for Innovative Research Ecosystem (ASPIRE), and the Terry Fox Research Institute (TFRI). This funding opportunity aims to unite interdisciplinary research teams to advance the biological and mechanistic understanding of cancer etiology, genesis, and risk to identify new targets and approaches for cancer prevention, risk reduction and early detection. CanPath and Atlantic PATH can provide letters of support for applicants using our data and biological samples. Registration deadline: April 1, 2025 Application deadline: June 19, 2025 Additional details: https://bit.ly/3PtR8SC Upcoming webinars: January 29, 12:30-2:00 PM ET | Register here. February 5, 12:30-2:00 PM ET | Register here